New Frailty Index Approach Predicts COVID-19 Mortality Risk

Wang S.(2021)AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells Cell Res. 31 126-140

Qiu Z.(2021)Leukocyte trafficking to the lungs and beyond: Lessons from influenza for COVID-19 Nat. Rev. Immunol 21 49-64

Hou Y.(2020)Body Localization of ACE-2: On the trail of the keyhole of SARS-CoV-2 Front. Med. (Lausanne) 7 594495-329

Deng X.(2021)Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19 Nat. Rev. Immunol. 21 319-803

Xu W.(2021)Pulmonary fibrosis secondary to COVID-19: A narrative review Expert Rev. Respir. Med. 15 791-6510

Zheng T.(2020)Geroprotective and senoremediative strategies to reduce the comorbidity, infection rates, severity, and lethality in gerophilic and gerolavic infections Aging (Albany, New York) 12 6492-9981

Wu P.(2020)Why does COVID-19 disproportionately affect older people?, Aging (Albany, New York) 12 9959-1242

Xie S.(2021)Characteristics, management, and prognosis of elderly patients with COVID-19 admitted in the ICU during the first wave: Insights from the COVID-ICU study: Prognosis of COVID-19 elderly critically ill patients in the ICU Ann. Intensive Care 11 77-2059

Bian W.(2020)Characteristics of and important lessons from the coronavirus disease, 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention JAMA 323 1239-95

Zhang C.(2020)Barnaby, D.P., Becker, L.B., Chelico, J.D., Cohen, S.L., Cookingham, J., Coppa, K., Diefenbach, M.A., Dominello, A.J., Duer-Hefele, J., Falzon, L., Gitlin, J., Hajizadeh, N., Harvin, T.G., Hirschwerk, D.A., Kim, E.J., Kozel, Z.M., Marrast, L.M., Mogavero, J.N., Osorio, G.A., Qiu, M., and Zanos, T.P., Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area JAMA 323 2052-782

Wang S.(2021)AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells Cell Res. 31 126-140

Qiu Z.(2021)Leukocyte trafficking to the lungs and beyond: Lessons from influenza for COVID-19 Nat. Rev. Immunol 21 49-64

Hou Y.(2020)Body Localization of ACE-2: On the trail of the keyhole of SARS-CoV-2 Front. Med. (Lausanne) 7 594495-329

Deng X.(2021)Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19 Nat. Rev. Immunol. 21 319-803

Xu W.(2021)Pulmonary fibrosis secondary to COVID-19: A narrative review Expert Rev. Respir. Med. 15 791-6510

Zheng T.(2020)Geroprotective and senoremediative strategies to reduce the comorbidity, infection rates, severity, and lethality in gerophilic and gerolavic infections Aging (Albany, New York) 12 6492-9981

Wu P.(2020)Why does COVID-19 disproportionately affect older people?, Aging (Albany, New York) 12 9959-1242

Xie S.(2021)Characteristics, management, and prognosis of elderly patients with COVID-19 admitted in the ICU during the first wave: Insights from the COVID-ICU study: Prognosis of COVID-19 elderly critically ill patients in the ICU Ann. Intensive Care 11 77-2059

Bian W.(2020)Characteristics of and important lessons from the coronavirus disease, 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention JAMA 323 1239-95

Zhang C.(2020)Barnaby, D.P., Becker, L.B., Chelico, J.D., Cohen, S.L., Cookingham, J., Coppa, K., Diefenbach, M.A., Dominello, A.J., Duer-Hefele, J., Falzon, L., Gitlin, J., Hajizadeh, N., Harvin, T.G., Hirschwerk, D.A., Kim, E.J., Kozel, Z.M., Marrast, L.M., Mogavero, J.N., Osorio, G.A., Qiu, M., and Zanos, T.P., Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area JAMA 323 2052-782